US-North Korea Summit Talks Resume: 4 MedTech Stocks To Watch

 | May 29, 2018 09:28PM ET

President Donald Trump’s calling off of the summit with North Korean leader Kim Jong Un last Thursday was quite a shocker.

The abandonement of summit plans dealt a blow to the underpenetrated and emerging markets of Asia, which are a solid source of revenues for more than 80% of U.S.-based multinational companies. The effects of the political mayhem caused the MSCI’s broadest index of Asia-Pacific shares outside Japan, South Korea’s KOSPI and Japan’s Nikkei to plummet.

Major Wall Street indices, S&P 500 and the Dow Jones Industrial Average, lost ground as well.

Considering this trend of downward movements, the White House decided to conduct the meeting. The United States announced its plans to send a “pre-advance team” to Singapore to prepare for Trump-Kim summit on Jun 12.

MedTech appears to be one of the very few sectors that might shelter investors from the political tension. Shrugging off the current volatility, the Medical-Products industry has returned 0.2% since the call-off against the S&P 500’s fall of 0.4%.